CN101380453A - Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof - Google Patents
Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof Download PDFInfo
- Publication number
- CN101380453A CN101380453A CNA2008100224149A CN200810022414A CN101380453A CN 101380453 A CN101380453 A CN 101380453A CN A2008100224149 A CNA2008100224149 A CN A2008100224149A CN 200810022414 A CN200810022414 A CN 200810022414A CN 101380453 A CN101380453 A CN 101380453A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- portions
- medicine
- moschus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an oral powder and an external plaster that are used for treating hyperosteogeny and rheumatoid arthritis and a preparation method thereof. The internal medicine comprises astragalus, codonopsis, Indian bread, glycyrrhiza, angelica, radix paeoniae alba, prepared rhizome of rehmannia, rhizoma chuanxiong, achyranthis bidentatae, eucommia, radix dipsaci, radix angelicae pubescentis, asarum, gentiana macrophylla, radix saposhnikoviae, dried ginger and musk, wherein, all the herbs except the musk are selected according to the required weight and crushed into powder; the musk is added into the powder; and the oral powder is obtained by blending evenly. The external medicine comprises the internal medicine materials, appropriate amount of beeswax and balm, wherein, the internal medicine materials except the musk are shredded and immersed in oil for 36 days and decocted and deslagged; medicinal oil is obtained; the beeswax and musk are added into the medicinal oil; and the external plaster is obtained by stirring and cooling. The external plaster is applied to the lesion by spreading on a black cloth. The invention is characterized by reinforcing both qi and blood, nourishing the liver and kidney, strengthening the bones and muscles, dredging the channels and collaterals, and is suitable for treating diseases in various parts of the human body, such as hyperosteogeny, rheumatoid arthritis, ankylosing spondylitis, femoral head necrosis.
Description
Technical field
The present invention relates to a kind of oral powder and Dressed plaster and method for making thereof for the treatment of hyperosteogeny and rheumatoid arthritis.Specifically be exactly method treatment hyperosteogeny and rheumatoid arthritis and method for making thereof, belong to medical technical field with oral Chinese medicine powder and Dressed plaster Chinese medicine.
Background technology
Modern medicine is thought: the pathogenic factor of hyperosteogeny: 1, congenital malformation; 2, wound, infection; 3, genetic defect; 4, general metabolism and cryptorrhea; 5, iatrogenic factors etc.The early stage slight dull pain of hyperosteogeny increases the weight of later on gradually, late period occurs deformity or rest pain, can't take care of oneself.
Modern medicine is thought: rheumatoid arthritis be a kind of cause of disease not sure as yet, have arthritis becomes a, chronic systemic disease.Its morbidity and bacterial infection, neuroregulation obstacle, endocrine regulation have certain relation.The various tissues in joint can be prolonged and constitute to pathological changes, as synovial membrane, cartilage, ligament, tendon and skeleton etc.Ankylosis and deformity late period then appears in the arthralgia and the dyskinesia that migration is arranged in early days, and with bone and skeletal muscle atrophy, the forfeiture self care ability.
Treat the method for hyperosteogeny and rheumatoid arthritis at present: 1, this Therapeutic Method of physiotherapy only is suitable for slight patient, and the patient with severe symptoms is invalid; 2, pharmacotherapy blood-activating and stasis-removing washout for oral administration, immersion etc. can only relief of symptoms, delay the course of disease.The non_steroidal anti_inflammatory drug thing also can only alleviating pain.3, operative therapy expense excessive risk is big, and operation back one is that easy recurrence, two causes patient's permanent disbility easily.
Up to the present people also do not find a kind of ideal medicament for the treatment of hyperosteogeny and rheumatoid arthritis.
Summary of the invention
The objective of the invention is provides a kind of oral powder and Dressed plaster and method for making thereof for the treatment of hyperosteogeny and rheumatoid arthritis at above-mentioned existing in prior technology deficiency.
Chinese medicine thinks that hyperosteogeny and rheumatoid arthritis belong to Chinese medicine De “ Paralysis disease " scope.It mainly is because energy and blood of human body two void that Chinese medicine is recognized generation for Paralysis disease, the Wei Bugu of battalion, and the wind-cold damp pathogen poison is attacked in an opponent's defence, multiple abscess meridians, joint, obstacle QI-blood circulation and falling ill.With the passing of time, deficiency of both the liver and kidney, muscles and bones mistake is supported, and QI-blood circulation is unsmooth, and body fluid is condensed into expectorant, so joint deformity, stiff.
According to the etiology and pathology of hyperosteogeny and rheumatoid arthritis, we have invented on the basis of secret prescription handed down in the family from generation to generation and have filled blood, the Chinese medicine for oral administration and the Dressed plaster of liver and kidney tonifying, bone and muscle strengthening and the meridian dredging.Like this medicine disease conform to, Chinese medicine, clinical use instant effect, cure rate height do not recur after more.
The described medicine of Chinese medicine for oral administration that the present invention treats hyperosteogeny and rheumatoid arthritis is combined by following raw material medicaments proportioning (weight portion):
Radix Astragali 28-82 part Radix Codonopsis 28-82 part Poria 18-68 part Radix Glycyrrhizae 8-38 part
Radix Angelicae Sinensis 22-72 part Radix Paeoniae Alba 22-72 part Radix Rehmanniae Preparata 48-98 part Rhizoma Chuanxiong 12-52 part
Cattle sunset 22-72 part Cortex Eucommiae 22-72 part Radix Dipsaci 22-72 part Radix Angelicae Pubescentis 22-72 part
Herba Asari 6-12 part Radix Gentianae Macrophyllae 22-72 part Radix Saposhnikoviae 22-72 part Rhizoma Zingiberis 12-52 part
Moschus 2-6 part
The described medicine of Chinese medicine for oral administration that the present invention treats hyperosteogeny and rheumatoid arthritis can be combined by following raw material medicaments proportioning (weight portion):
8 parts in 18 portions of Radix Glycyrrhizaes of 28 parts of Poria of 28 parts of Radix Codonopsis of the Radix Astragali
12 parts of 48 parts of Rhizoma Chuanxiongs of 22 parts of Radix Rehmanniaes Preparata of 22 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
22 parts of 22 parts of Radix Angelicae Pubescentiss of 22 parts of Radix Dipsaci of cattle sunset 22 parts of Cortexs Eucommiae
12 parts of 22 portions of Rhizoma Zingiberiss of 22 parts of Radix Saposhnikoviaes of 6 portions of Radix Gentianae Macrophyllae of Herba Asari
2 parts in Moschus
The described medicine of Chinese medicine for oral administration that the present invention treats hyperosteogeny and rheumatoid arthritis also can be combined by following raw material medicaments proportioning (weight portion):
28 parts in 38 portions of Radix Glycyrrhizaes of 58 parts of Poria of 58 parts of Radix Codonopsis of the Radix Astragali
28 parts of 76 parts of Rhizoma Chuanxiongs of 46 parts of Radix Rehmanniaes Preparata of 46 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
46 parts of 46 parts of Radix Angelicae Pubescentiss of 46 parts of Radix Dipsaci of cattle sunset 46 parts of Cortexs Eucommiae
28 parts of 46 portions of Rhizoma Zingiberiss of 46 parts of Radix Saposhnikoviaes of 14 portions of Radix Gentianae Macrophyllae of Herba Asari
4 parts in Moschus
The described medicine of Chinese medicine for oral administration that the present invention treats hyperosteogeny and rheumatoid arthritis also can be combined by following raw material medicaments proportioning (weight portion):
38 parts in 68 portions of Radix Glycyrrhizaes of 82 parts of Poria of 82 parts of Radix Codonopsis of the Radix Astragali
52 parts of 98 parts of Rhizoma Chuanxiongs of 72 parts of Radix Rehmanniaes Preparata of 72 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
72 parts of 72 parts of Radix Angelicae Pubescentiss of 72 parts of Radix Dipsaci of cattle sunset 72 parts of Cortexs Eucommiae
52 parts of 72 portions of Rhizoma Zingiberiss of 72 parts of Radix Saposhnikoviaes of 21 portions of Radix Gentianae Macrophyllae of Herba Asari
6 parts in Moschus
The present invention treats the crude drug Radix Astragali, Radix Codonopsis, Poria, the Radix Glycyrrhizae QI invigorating and body resistance strengthening of hyperosteogeny and rheumatoid arthritis; Radix Angelicae Sinensis, the Radix Paeoniae Alba, Radix Rehmanniae Preparata, Rhizoma Chuanxiong and nutrition blood, and energy promoting blood circulation by removing wind; Niu Xi, the Cortex Eucommiae, Radix Dipsaci liver and kidney tonifying, bone and muscle strengthening, remove rheumatism; Radix Angelicae Pubescentis, Herba Asari are gone into kidney and are searched wind, the wind damp eliminating ， Juan Paralysis pain relieving of loosing; Radix Gentianae Macrophyllae, Radix Saposhnikoviae expelling wind and removing dampness; The Rhizoma Zingiberis dispelling cold by warming the meridian; The Moschus the meridian dredging, open all keys, saturating flesh bone.Summarize characteristics of the present invention and be fill blood, liver and kidney tonifying, bone and muscle strengthening, the meridian dredging, adapt to the diseases such as hyperosteogeny, rheumatoid arthritis, ankylosing spondylitis, femur head necrosis of treatment partes corporis humani position.
Above-mentioned each component can be made said dosage form on any pharmaceutics, and as dosage forms such as granule, powder, tablet, capsule, decoctions, the preferred dosage form of the present invention is a powder.
The preparation method that the present invention treats the oral medicine of hyperosteogeny and rheumatoid arthritis is: except that Moschus, be 120 orders by the selected drying and crushing of required weight, more required weight Moschus put into wherein mixing the above-mentioned raw materials medicine, oral medicine of the present invention.
Dressed plaster of the present invention adds an amount of Cera Flava by above-mentioned oral medicine and an amount of Oleum sesami is formed.
The preparation method of Dressed plaster of the present invention is: above-mentioned oral medicine is except that Moschus, all the other crude drug are selected by required weight, chopping is gone into oil (consumption of oil was not advisable for 10 centimetres to have powder) and was soaked 36 days, endure to whole Chinese medicines dried-up with slow fire, remove slag, continue to endure the medicine oil in the pot, endure to drip into and put into an amount of Cera Flava (consumption of wax be about crude drug weight 1/3rd) behind the pearl, after stirring 30 minutes with Ramulus Persicae, put the Moschus oil that is used as medicine again, with Ramulus Mori stir about 30 minutes, cut off burning things which may cause a fire disaster then, cooling back Dressed plaster of the present invention, the time spent spreads out and be affixed on the affected part on black cloth.Dressed plaster applies in the affected part, by dermal osmosis, is fully absorbed by blood capillary, directly enters focus, has played the oral medicine effect that is beyond one's reach.
Method treatment hyperosteogeny and rheumatoid arthritis curative effect with Orally taken and externally are very good.
Therapeutic Method 1, Chinese medicine for oral administration: a, every day three times, each 6 grams, old man, weak, child cut down according to the circumstance (as it is same to take tablet, its consumption of pill and powder that this powder makes).B, this powder are put eliminating cold for resuscitation water furnishing gruel sample taking medicine before meal usefulness in the container.2, Dressed plaster: paste and the affected part, changed in 6 days one, 30 days is a course of treatment.
Points for attention: 1, the anemia of pregnant woman prohibits clothes.2, avoid eating anything raw or cold food, Semen phaseoli radiati, seafood, cigarette, wine etc.
The invention has the beneficial effects as follows: the present invention treats hyperosteogeny and the rheumatoid arthritis Orally taken and externally uses simultaneously, and curative effect is very good.Some cases statistics that below will be more complete is listed as follows:
Hyperosteogeny:
Treatment number: 310 people, wherein male 174 people, women 136 people.
Patient age: 30-40 year 60 people, 40-50 year 120 people, 130 people more than 50 years old.
Medical history: 1-5 160 people, 5-10 100 people, 50 people more than 10 years.
Healing time: 1-3 month 210 people, 3-5 month 86 people, 14 people more than 5 months.
Wherein: hyperosteogeny of cervical vertebra 106 people, lumbar vertebra hyperosteogeny 83 people
Upper limb joint hyperosteogeny 71 people, joint of the lower extremity hyperosteogeny 50 people
Rheumatoid arthritis:
Treatment number: 96 people, wherein male 25 people, women 71 people.
Patient age: 20-30 year 31 people, 30-40 year 36 people, 29 people more than 40 years old.
Medical history: 1-5 32 people, 5-10 43 people, 21 people more than 10 years.
Healing time: 1-4 month 51 people, 4-6 month 38 people, 7 people more than 6 months.
Criterion of therapeutical effect: (diagnostic criteria) carried out with reference to " the clinical research guideline of new Chinese medicine Zhi Liao Paralysis disease ".
Clinical cure: symptom all disappears, and it is normal that functional activity recovers; Main doctor trained in Western medicine physical and chemical index inspection is normal.
Produce effects: symptomatology disappears or cardinal symptom disappears, and function of joint is recovered substantially, can participate in normal work or physical labor; The physical and chemical index inspection is normal substantially.
Effectively: cardinal symptom disappears substantially, and main function of joint is recovered substantially or had made marked progress, and can't take care of oneself transfers to and can take care of oneself, or loses the job and recover with work capacity is existing; Main physical and chemical index makes moderate progress.
Invalid: with the treatment before compare, each side does not all have progress.
Case 1
Well, the man, 46 years old, the cadre, examine in January, 2006, and chronognosis is dizzy dizzy in recent years, and neck acid is expanded, and right upper extremity is tingle, and throat vertebra lateral projection shows: physiological bending disappears, and the upper limb sclerotin all is lip sample hypertrophy before and after the 3.4.5 vertebral body.Be diagnosed as hyperosteogeny of cervical vertebra.Use Orally taken and externally of the present invention to treat simultaneously 40 days, transference cure, throat vertebra lateral projection shows: physiological bending is normal, the vertebral body no abnormality seen.The sick announcement fully recovered.Follow up a case by regular visits to not recurrence in 2 years.
Case 2
Lee, woman 42 years old, dizziness headache, hypomnesis in recent years, blood pressure is normal, through X-ray check cervical vertebra 3-5 joint hyperosteogeny, with Orally taken and externally treatment of the present invention recovery from illness in 20 days.
Case 3
Ma, 40 years old, the man, people from Shandong, right upper extremity elbow joint osteoarthritis, tingle pain over 3 years is through Orally taken and externally treatment of the present invention recovery from illness in 40 days.
Case 4
The Wang, the man, 61 years old, long-term pain in the lumbar region was diagnosed as lumbar vertebra hyperosteogeny through the X sheet, with Orally taken and externally treatment of the present invention recovery from illness in 20 days.
Case 5
Hair certain, the man, 48 years old, knee joint hyperosteogeny in this year, difficulty in walking is with internal and external medicine treatment of the present invention recovery from illness in 25 days.
Case 6
Liu, the woman, 50 years old, the cadre, 1987 are ill, be diagnosed as rheumatoid arthritis through local county hospital, the back is to Beijing, Shanghai, Nanjing, seeking medical advice in ground such as Hubei, controls heavier and heavier, is unable to leave the bed at the bottom of calendar year 2001, can't take care of oneself, the whole body joint deformity, stiff, pain, two wrists are stiff, ten refer to gooseneck shape deformity, and duplex flexing difficulty is stretched, the both shoulders ankylosis, hip knee joint ankle is stiff, ten microdactyly bendings, two wrists, buttocks, ankle, waist, the subcutaneous rheumatism tuberosity that occurs in many places, position such as elbow, big about goose egg is big, big as Ovum Anas domestica successively, egg is big, Ovum Columba livia is big, bean very much not waits.Because the life-time service amcinonide, it is impaired to cause many internal organs, cerebellar atrophy wherein, and left kidney is more half as large than right kidney, and anorexia, Chang Duori can not separate stool, and misery is felt embarrassed to mention.December rose and used Orally taken and externally of the present invention to treat recovery from illness in 120 days altogether on the 26th calendar year 2001, recurred so far.
The specific embodiment
Embodiment 1:
The described medicine of Chinese medicine for oral administration that the present invention treats hyperosteogeny and rheumatoid arthritis can be combined by following raw material medicaments proportioning (weight portion):
8 parts in 18 portions of Radix Glycyrrhizaes of 28 parts of Poria of 28 parts of Radix Codonopsis of the Radix Astragali
12 parts of 48 parts of Rhizoma Chuanxiongs of 22 parts of Radix Rehmanniaes Preparata of 22 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
22 parts of 22 parts of Radix Angelicae Pubescentiss of 22 parts of Radix Dipsaci of cattle sunset 22 parts of Cortexs Eucommiae
12 parts of 22 portions of Rhizoma Zingiberiss of 22 parts of Radix Saposhnikoviaes of 6 portions of Radix Gentianae Macrophyllae of Herba Asari
2 parts in Moschus
Embodiment 2:
The described medicine of Chinese medicine for oral administration that the present invention treats hyperosteogeny and rheumatoid arthritis also can be combined by following raw material medicaments proportioning (weight portion):
28 parts in 38 portions of Radix Glycyrrhizaes of 58 parts of Poria of 58 parts of Radix Codonopsis of the Radix Astragali
28 parts of 76 parts of Rhizoma Chuanxiongs of 46 parts of Radix Rehmanniaes Preparata of 46 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
46 parts of 46 parts of Radix Angelicae Pubescentiss of 46 parts of Radix Dipsaci of cattle sunset 46 parts of Cortexs Eucommiae
28 parts of 46 portions of Rhizoma Zingiberiss of 46 parts of Radix Saposhnikoviaes of 14 portions of Radix Gentianae Macrophyllae of Herba Asari
4 parts in Moschus
Embodiment 3:
The described medicine of Chinese medicine for oral administration that the present invention treats hyperosteogeny and rheumatoid arthritis also can be combined by following raw material medicaments proportioning (weight portion):
38 parts in 68 portions of Radix Glycyrrhizaes of 82 parts of Poria of 82 parts of Radix Codonopsis of the Radix Astragali
52 parts of 98 parts of Rhizoma Chuanxiongs of 72 parts of Radix Rehmanniaes Preparata of 72 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
72 parts of 72 parts of Radix Angelicae Pubescentiss of 72 parts of Radix Dipsaci of cattle sunset 72 parts of Cortexs Eucommiae
52 parts of 72 portions of Rhizoma Zingiberiss of 72 parts of Radix Saposhnikoviaes of 21 portions of Radix Gentianae Macrophyllae of Herba Asari
6 parts in Moschus
Embodiment 4:
Above-mentioned each component can be made said dosage form on any pharmaceutics, and the preferred dosage form of the present invention is a powder.
Embodiment 5:
With the preparation method of above-mentioned each component preparation cost invention oral powder be: except that Moschus, be 120 orders by the selected drying and crushing of required weight, more required weight Moschus put into wherein mixing above-mentioned medicine, oral powder of the present invention.
Embodiment 6:
Dressed plaster of the present invention adds an amount of Cera Flava by above-mentioned oral medicine and an amount of Oleum sesami is formed.
Embodiment 7:
The preparation method of Dressed plaster of the present invention is: above-mentioned oral medicine is except that Moschus, all the other crude drug are selected by required weight, chopping is gone into oil (consumption of oil was not advisable for 10 centimetres to have powder) and was soaked 36 days, endure to whole Chinese medicines dried-up with slow fire, remove slag, continue to endure the medicine oil in the pot, endure to drip into and put into an amount of Cera Flava (mellisic consumption be about crude drug weight for oral administration 1/3rd) behind the pearl, after stirring 30 minutes with Ramulus Persicae, put into Moschus again and use Ramulus Mori stir about 30 minutes, cut off burning things which may cause a fire disaster then, cooling back Dressed plaster of the present invention, the time spent spreads out and paste the affected part on black cloth.
Claims (6)
1, a kind of oral powder and Dressed plaster for the treatment of hyperosteogeny and rheumatoid arthritis is characterized in that: the effective component content of described medicine is [weight portion]:
Radix Astragali 28-82 part Radix Codonopsis 28-82 part Poria 18-68 part Radix Glycyrrhizae 8-38 part
Radix Angelicae Sinensis 22-72 part Radix Paeoniae Alba 22-72 part Radix Rehmanniae Preparata 48-98 part Rhizoma Chuanxiong 12-52 part
Cattle sunset 22-72 part Cortex Eucommiae 22-72 part Radix Dipsaci 22-72 part Radix Angelicae Pubescentis 22-72 part
Herba Asari 6-12 part Radix Gentianae Macrophyllae 22-72 part Radix Saposhnikoviae 22-72 part Rhizoma Zingiberis 12-52 part
Moschus 2-6 part.
2, according to claims 1 described medicine, it is characterized in that: the effective component content of described medicine is [weight portion]:
8 parts in 18 portions of Radix Glycyrrhizaes of 28 parts of Poria of 28 parts of Radix Codonopsis of the Radix Astragali
12 parts of 48 parts of Rhizoma Chuanxiongs of 22 parts of Radix Rehmanniaes Preparata of 22 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
22 parts of 22 parts of Radix Angelicae Pubescentiss of 22 parts of Radix Dipsaci of cattle sunset 22 parts of Cortexs Eucommiae
12 parts of 22 portions of Rhizoma Zingiberiss of 22 parts of Radix Saposhnikoviaes of 6 portions of Radix Gentianae Macrophyllae of Herba Asari
2 parts in Moschus.
3, according to claims 1 described medicine, it is characterized in that: the effective component content of described medicine is [weight portion]:
28 parts in 38 portions of Radix Glycyrrhizaes of 58 parts of Poria of 58 parts of Radix Codonopsis of the Radix Astragali
28 parts of 76 parts of Rhizoma Chuanxiongs of 46 parts of Radix Rehmanniaes Preparata of 46 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
46 parts of 46 parts of Radix Angelicae Pubescentiss of 46 parts of Radix Dipsaci of cattle sunset 46 parts of Cortexs Eucommiae
28 parts of 46 portions of Rhizoma Zingiberiss of 46 parts of Radix Saposhnikoviaes of 14 portions of Radix Gentianae Macrophyllae of Herba Asari
4 parts in Moschus.
4, according to claims 1 described medicine, it is characterized in that: the effective component content of described medicine is [weight portion]:
38 parts in 68 portions of Radix Glycyrrhizaes of 82 parts of Poria of 82 parts of Radix Codonopsis of the Radix Astragali
52 parts of 98 parts of Rhizoma Chuanxiongs of 72 parts of Radix Rehmanniaes Preparata of 72 portions of Radix Paeoniae Albas of Radix Angelicae Sinensis
72 parts of 72 parts of Radix Angelicae Pubescentiss of 72 parts of Radix Dipsaci of cattle sunset 72 parts of Cortexs Eucommiae
52 parts of 72 portions of Rhizoma Zingiberiss of 72 parts of Radix Saposhnikoviaes of 21 portions of Radix Gentianae Macrophyllae of Herba Asari
6 parts in Moschus.
5, according to the oral powder and the Dressed plaster of claims 1 or 2 or 3 or 4 described treatment hyperosteogenys and rheumatoid arthritis, it is characterized in that: the preparation method of oral powder is: be 120 orders with the above-mentioned raw materials medicine by the selected drying and crushing of required weight except that Moschus, again required weight Moschus is put into wherein mixing, oral powder of the present invention.
6, oral powder and Dressed plaster according to claims 1 or 2 or 3 or 4 described treatment hyperosteogenys and rheumatoid arthritis, it is characterized in that: with the preparation method of above-mentioned oral medicine each component preparation cost invention Dressed plaster be: above-mentioned crude drug for oral administration is except that Moschus, all the other crude drug are selected by required weight, chopping is gone into oil [consumption of oil was not advisable for 10 centimetres to have powder] and was soaked 36 days, endure to Chinese medicine all dried-up with slow fire, remove slag, continue to endure the medicine oil in the pot, endure to drip into and put into an amount of Cera Flava [consumption of wax be about crude drug weight for oral administration 1/3rd] behind the pearl, after stirring 30 minutes with Ramulus Persicae, put the Moschus oil that is used as medicine again, with Ramulus Mori stir about 30 minutes, cut off burning things which may cause a fire disaster then, cooling back Dressed plaster of the present invention, the time spent spreads out and paste the affected part on black cloth.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100224149A CN101380453B (en) | 2008-07-21 | 2008-07-21 | Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100224149A CN101380453B (en) | 2008-07-21 | 2008-07-21 | Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101380453A true CN101380453A (en) | 2009-03-11 |
| CN101380453B CN101380453B (en) | 2011-04-20 |
Family
ID=40460623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100224149A Expired - Fee Related CN101380453B (en) | 2008-07-21 | 2008-07-21 | Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101380453B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101926878A (en) * | 2010-06-03 | 2010-12-29 | 陕西中医学院 | Chinese medicinal composition for treating osteoarthritis and preparation method thereof |
| CN102580049A (en) * | 2012-03-27 | 2012-07-18 | 房学锋 | Externally applied traditional Chinese medicine combination for treating osteoarthritis through applying iontophoresis and preparation method |
| CN104127847A (en) * | 2014-08-07 | 2014-11-05 | 殷波 | Traditional Chinese medicine composition for treating femoral head necrosis |
| CN104225058A (en) * | 2014-10-06 | 2014-12-24 | 李先强 | Traditional Chinese medicinal pill for treating rheumatoid spondylitis |
| CN104491795A (en) * | 2014-12-16 | 2015-04-08 | 广东聚智诚科技有限公司 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN104771489A (en) * | 2015-04-26 | 2015-07-15 | 李厚建 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN104958525A (en) * | 2015-08-04 | 2015-10-07 | 青岛蓝盛洋医药生物科技有限责任公司 | Traditional Chinese medicine composition for treating chronic infectious arthritis and preparation method of traditional Chinese medicine composition |
| CN114617941A (en) * | 2020-12-11 | 2022-06-14 | 中国人民解放军空军军医大学 | A pharmaceutical composition for treating ankylosing spondylitis and/or rheumatoid arthritis |
-
2008
- 2008-07-21 CN CN2008100224149A patent/CN101380453B/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101926878A (en) * | 2010-06-03 | 2010-12-29 | 陕西中医学院 | Chinese medicinal composition for treating osteoarthritis and preparation method thereof |
| CN101926878B (en) * | 2010-06-03 | 2014-10-29 | 陕西中医学院 | Chinese medicinal composition for treating osteoarthritis and preparation method thereof |
| CN102580049A (en) * | 2012-03-27 | 2012-07-18 | 房学锋 | Externally applied traditional Chinese medicine combination for treating osteoarthritis through applying iontophoresis and preparation method |
| CN102580049B (en) * | 2012-03-27 | 2013-11-20 | 房学锋 | Externally applied traditional Chinese medicine combination for treating osteoarthritis through applying iontophoresis and preparation method |
| CN104127847A (en) * | 2014-08-07 | 2014-11-05 | 殷波 | Traditional Chinese medicine composition for treating femoral head necrosis |
| CN104225058A (en) * | 2014-10-06 | 2014-12-24 | 李先强 | Traditional Chinese medicinal pill for treating rheumatoid spondylitis |
| CN104491795A (en) * | 2014-12-16 | 2015-04-08 | 广东聚智诚科技有限公司 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN104771489A (en) * | 2015-04-26 | 2015-07-15 | 李厚建 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN104958525A (en) * | 2015-08-04 | 2015-10-07 | 青岛蓝盛洋医药生物科技有限责任公司 | Traditional Chinese medicine composition for treating chronic infectious arthritis and preparation method of traditional Chinese medicine composition |
| CN114617941A (en) * | 2020-12-11 | 2022-06-14 | 中国人民解放军空军军医大学 | A pharmaceutical composition for treating ankylosing spondylitis and/or rheumatoid arthritis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101380453B (en) | 2011-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101366919B (en) | Traditional Chinese medicine ointment for treating rheumatism diseases | |
| CN101411802B (en) | Black plaster for treating hyperosteogeny and preparation method thereof | |
| CN101380453B (en) | Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof | |
| CN101890104B (en) | Chinese medicament for treating neck, shoulder, waist and leg pains | |
| CN100551422C (en) | A kind of endo-medicine for the treatment of intervertebral disk hernia | |
| CN101337059A (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
| CN101507802A (en) | Medicine for treating ankylosing spondylitis | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN101897882B (en) | Medicament for treating and breast lobular hyperplasia and cyst | |
| CN101549137A (en) | Chinese medicine preparation for treating bone joint disease | |
| CN102293853A (en) | Chinese medicinal pills for treating Bi syndrome | |
| CN102755622B (en) | Medicine for treating rheumatoid arthritis | |
| CN106177819A (en) | A kind of external medicine composition for cervical spondylosis, preparation method and applications | |
| CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN102048863A (en) | Traditional Chinese medicine for treating lumbar hyperosteogeny | |
| CN101347558A (en) | Chinese medicine for treating rheumatism osteonosus | |
| CN102657761A (en) | Patch for treating rheumatoid arthritis and preparation method for patch | |
| CN102512560A (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN101380425B (en) | Arthrosis pill | |
| CN101214323B (en) | Orally-taken powder medicine and externally-applied plaster for treating angitis and preparation thereof | |
| CN102600251A (en) | Compound rheumatism-rehabilitating composite agent | |
| CN101637535B (en) | Medicine for treating bone hyperplasia and preparation method thereof | |
| CN101862430B (en) | Chinese medicament for treating femoral head necrosis and preparation method thereof | |
| CN101485718B (en) | Medicament for treating rheumatic osteonosus and preparation method thereof | |
| CN105560537A (en) | Medicine composition for treating osteoartritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Cuixia Document name: Notification to Pay the Fees |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110420 Termination date: 20130721 |